Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksATK.L Regulatory News (ATK)

  • There is currently no data for ATK

Form 8.3 - WS ATKINS PLC

25 May 2017 15:08

FORM 8.5 (EPT/NON-RI)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (“RI”) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose WS ATKINS PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 24 May 2017
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 0.5p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 1,163,333 1.16% 1,003,716 1.00%
(2) Cash-settled derivatives:
63,359 0.06% 995,972 0.99%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 1,226,692 1.23% 1,999,688 2.00%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
0.5p ordinary Purchase 32 20.8593 GBP
0.5p ordinary Purchase 32 20.8600 GBP
0.5p ordinary Purchase 37 20.8900 GBP
0.5p ordinary Purchase 70 20.8814 GBP
0.5p ordinary Purchase 96 20.8800 GBP
0.5p ordinary Purchase 130 20.9000 GBP
0.5p ordinary Purchase 150 20.8836 GBP
0.5p ordinary Purchase 177 20.8846 GBP
0.5p ordinary Purchase 414 20.8590 GBP
0.5p ordinary Purchase 473 20.8700 GBP
0.5p ordinary Purchase 1,031 20.8692 GBP
0.5p ordinary Purchase 1,339 20.8979 GBP
0.5p ordinary Purchase 1,477 20.8863 GBP
0.5p ordinary Purchase 3,323 20.8925 GBP
0.5p ordinary Purchase 14,117 20.8737 GBP
0.5p ordinary Sale 74 20.9087 GBP
0.5p ordinary Sale 83 20.8838 GBP
0.5p ordinary Sale 96 20.8800 GBP
0.5p ordinary Sale 130 20.9000 GBP
0.5p ordinary Sale 186 20.8737 GBP
0.5p ordinary Sale 255 20.8698 GBP
0.5p ordinary Sale 327 20.8848 GBP
0.5p ordinary Sale 473 20.8700 GBP
0.5p ordinary Sale 678 20.8600 GBP
0.5p ordinary Sale 737 20.8900 GBP
0.5p ordinary Sale 1,960 20.8753 GBP
0.5p ordinary Sale 4,720 20.8795 GBP
0.5p ordinary Sale 8,440 20.8799 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
0.5p ordinary CFD Long 74 20.9087 GBP
0.5p ordinary SWAP Long 916 20.8835 GBP
0.5p ordinary SWAP Long 1,038 20.8842 GBP
0.5p ordinary SWAP Long 12,244 20.8795 GBP
0.5p ordinary CFD Short 70 20.8814 GBP
0.5p ordinary SWAP Short 127 20.8602 GBP
0.5p ordinary SWAP Short 1,268 20.8849 GBP
0.5p ordinary CFD Short 1,339 20.8979 GBP
0.5p ordinary CFD Short 2,786 20.8948 GBP
0.5p ordinary CFD Short 3,039 20.8869 GBP
0.5p ordinary CFD Short 3,323 20.8925 GBP
0.5p ordinary SWAP Short 7,197 20.8600 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 25 May 2017
Contact name: Femi Badmos
Telephone number: 020 3555 1125

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170525005638/en/

Copyright Business Wire 2017

Date   Source Headline
26th Sep 201112:20 pmRNSDirector/PDMR Shareholding
16th Sep 20112:55 pmRNSDirector/PDMR Shareholding
15th Sep 20115:13 pmRNSDirector Declaration
9th Sep 20117:00 amRNSResult of AGM
8th Sep 20114:30 pmRNSDirectorate Change
8th Sep 20114:30 pmRNSAGM Statement
8th Sep 20114:30 pmRNSDirectorate Change
16th Aug 20113:11 pmRNSDirector/PDMR Shareholding
3rd Aug 20117:00 amRNSInterim Management Statement
29th Jul 201112:35 pmRNSAnnual Information Update
18th Jul 20114:04 pmRNSDirector/PDMR Shareholding
5th Jul 20114:30 pmRNSHolding(s) in Company
1st Jul 20114:30 pmRNSAnnual Financial Report
21st Jun 20115:52 pmRNSDirector/PDMR Shareholding
17th Jun 20112:14 pmRNSDirector/PDMR Shareholding
16th Jun 20117:01 amRNSDirectorate Change
16th Jun 20117:00 amRNSFinal Results
15th Jun 20115:15 pmRNSDirector/PDMR Shareholding
6th Jun 20117:00 amRNSAtkins pension plan agreement
6th Jun 20117:00 amRNSAcquisition
2nd Jun 20117:00 amRNSDirectorate Change
1st Jun 201110:03 amRNSHolding(s) in Company
17th May 20111:59 pmRNSDirector/PDMR Shareholding
18th Apr 20114:54 pmRNSDirector/PDMR Shareholding
13th Apr 20117:00 amRNSTrading Statement
5th Apr 20113:56 pmRNSDirector/PDMR Shareholding
16th Mar 20114:43 pmRNSDirector/PDMR Shareholding
14th Mar 20117:00 amRNSAcquisition
16th Feb 20113:46 pmRNSDirector/PDMR Shareholding
16th Feb 20117:16 amRNSAnalyst conference call
16th Feb 20117:00 amRNSInterim Management Statement
10th Feb 20117:00 amRNSAnalyst Presentation
2nd Feb 20115:23 pmRNSDirector/PDMR Shareholding
2nd Feb 20119:00 amRNSDirector/PDMR Shareholding
18th Jan 20112:40 pmRNSDirector/PDMR Shareholding
17th Dec 20101:55 pmRNSDirector/PDMR Shareholding
30th Nov 20101:59 pmRNSDirector/PDMR Shareholding
25th Nov 20107:00 amRNSHalf Yearly Report
17th Nov 20108:25 amRNSDirector/PDMR Shareholding
8th Nov 201010:00 amRNSAcquisition
28th Oct 20109:17 amRNSDirector Declaration
19th Oct 201010:32 amRNSDirector/PDMR Shareholding
19th Oct 20108:53 amRNSDirector/PDMR Shareholding
14th Oct 201012:03 pmRNSDirector/PDMR Shareholding
5th Oct 20104:05 pmRNSDirector/PDMR Shareholding
4th Oct 20107:00 amRNSWS Atkins plc completes acquisition of PBSJ
1st Oct 20106:13 pmRNSAcquisition Update
30th Sep 20103:12 pmRNSDirector/PDMR Shareholding
30th Sep 20102:56 pmRNSDirector/PDMR Shareholding
27th Sep 20105:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.